Skip to main content
Joe Verghese, MD, Neurology, Lake Grove, NY

JoeVergheseMD

Neurology • Lake Grove, NY

Dementia & Geriatrics

Professor and Chair, Department of Neurology Renaissance School of Medicine, Stony Brook, NY

Join to view full profile

Dr. Verghese is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Verghese's full profile

Already have an account?

  • Office

    Neurology Associates of Stony Brook
    4 Smith Haven Mall Suite 105
    Lake Grove, NY 11755
    Phone+1 631-444-2599
    Fax+1 631-392-7213

Summary

  • Dr. Joe Verghese is a neurologist based in Lake Grove, NY, with subspecialties in dementia and geriatrics. He completed his medical education at St. John's Medical College, followed by a neurology residency and clinical neurophysiology fellowship at Montefiore Medical Center/Albert Einstein College of Medicine. Dr. Verghese was a professor at Montefiore Medical Center - Einstein Campus from 2000 to 2024. He is currently professor and Chair of Neurology at the Renaissance School of Medicine, Stony Brook University - since 2024. He has published over 300 research papers and reviews in notable journals. He serves as the principal investigator for multiple NIH studies including the clinical trial "5-Cog 2.0: A Pragmatic Clinical Trial."

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Clinical Neurophysiology, 1998 - 1999
  • Montefiore Medical Center/Albert Einstein College of Medicine
    Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 1995 - 1998
  • St. John's Medical College
    St. John's Medical CollegeClass of 1989

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2004 - 2027
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Slower Walking in Older Adults Could Signal Early Dementia, Study Finds
    Slower Walking in Older Adults Could Signal Early Dementia, Study FindsDecember 6th, 2024
  • Walking on Curved Path Can Give Clues to Cognitive Decline, Researchers Find
    Walking on Curved Path Can Give Clues to Cognitive Decline, Researchers FindMarch 30th, 2024
  • Quick Test Helps Detect Dementia
    Quick Test Helps Detect DementiaJune 8th, 2024

Grant Support

  • Gait as a Preclinical Marker for Alzheimer’s Disease and Dementia: insights from super-movers, usual-movers, and slow-moversALBERT EINSTEIN COLLEGE OF MEDICINE2024–2029
  • Gait as a Preclinical Marker for Alzheimer’s Disease and Dementia: insights from super-movers, usual-movers, and slow-moversALBERT EINSTEIN COLLEGE OF MEDICINE2024–2029
  • Gait as a Preclinical Marker for Alzheimer’s Disease and Dementia: insights from super-movers, usual-movers, and slow-moversALBERT EINSTEIN COLLEGE OF MEDICINE2024–2029
  • Cognitive decline and dementia in older Kerala AmericansALBERT EINSTEIN COLLEGE OF MEDICINE2024–2029
  • Gait as a Preclinical Marker for Alzheimer’s Disease and Dementia: insights from super-movers, usual-movers, and slow-moversALBERT EINSTEIN COLLEGE OF MEDICINE2024–2029
  • Multi-omics approach to frailty resilienceALBERT EINSTEIN COLLEGE OF MEDICINE2014–2029
  • Multi-omics approach to frailty resilienceALBERT EINSTEIN COLLEGE OF MEDICINE2014–2029
  • Multi-omics approach to frailty resilienceALBERT EINSTEIN COLLEGE OF MEDICINE2014–2029
  • Multi-omics approach to frailty resilienceALBERT EINSTEIN COLLEGE OF MEDICINE2014–2029
  • 5-Cog Paradigm to Improve Detection of Cognitive Impairment in Primary Care: Pragmatic Clinical TrialALBERT EINSTEIN COLLEGE OF MEDICINE2017–2027
  • 5-Cog Paradigm to Improve Detection of Cognitive Impairment in Primary Care: Pragmatic Clinical TrialALBERT EINSTEIN COLLEGE OF MEDICINE2017–2027
  • 5-Cog Paradigm to Improve Detection of Cognitive Impairment in Primary Care: Pragmatic Clinical TrialALBERT EINSTEIN COLLEGE OF MEDICINE2017–2027
  • 5-Cog Paradigm to Improve Detection of Cognitive Impairment in Primary Care: Pragmatic Clinical TrialALBERT EINSTEIN COLLEGE OF MEDICINE2017–2027
  • 5-Cog Paradigm to Improve Detection of Cognitive Impairment in Primary Care: Pragmatic Clinical TrialALBERT EINSTEIN COLLEGE OF MEDICINE2017–2027
  • Non-Invasive Home Neurostimulation for Mild to Moderate Alzheimer's Disease: Double-Blind, Sham Controlled Randomized Clinical TrialALBERT EINSTEIN COLLEGE OF MEDICINE2020–2025
  • Non-Invasive Home Neurostimulation for Mild to Moderate Alzheimer's Disease: Double-Blind, Sham Controlled Randomized Clinical TrialALBERT EINSTEIN COLLEGE OF MEDICINE2020–2025
  • The biological underpinnings of Motoric Cognitive Risk syndrome: a multi-center studyALBERT EINSTEIN COLLEGE OF MEDICINE2020–2025
  • Non-Invasive Home Neurostimulation for Mild to Moderate Alzheimer's Disease: Double-Blind, Sham Controlled Randomized Clinical TrialALBERT EINSTEIN COLLEGE OF MEDICINE2020–2025
  • Non-Invasive Home Neurostimulation for Mild to Moderate Alzheimer's Disease: Double-Blind, Sham Controlled Randomized Clinical TrialALBERT EINSTEIN COLLEGE OF MEDICINE2020–2025
  • Kerala-Einstein Aging StudyALBERT EINSTEIN COLLEGE OF MEDICINE2011–2025

Professional Memberships

Dr. Joe Verghese, Dr. Joe Verghese, MD, Dr. J Verghese